R. Boer et al., INTERACTION OF CYTOSTATICS AND CHEMOSENSITIZERS WITH THE DEXNIGULDIPINE BINDING-SITE ON P-GLYCOPROTEIN, European journal of pharmacology, 295(2-3), 1996, pp. 253-260
The interaction of cytostatics and chemosensitizers with the dexniguld
ipine binding site of P-glycoprotein was investigated in photoaffinity
labeling experiments. A tritiated azidoderivative of the chemosensiti
zer dexniguldipine with dihydropyridine structure, [H-3]B9209-005, was
used to irreversibly label P-glycoprotein. The apparent affinity of c
ytostatics and chemosensitizers to this binding site was estimated fro
m labeling experiments in the presence of increasing concentrations of
compounds. From the cytostatics tested, the vinca alkaloids and taxol
showed the highest affinity, anthracyclins possessed moderate affinit
y while methotrexate, ara C and camptothecin, cytostatics not involved
in P-glycoprotein-mediated multidrug resistance, were almost inactive
. The chemosensitizers GF 120918, cyclosporin A and SDZ PSC-833 inhibi
ted photoincorporation with the highest potency. Steep dose-inhibition
curves were obtained with the cyclic peptides and S9788, indicating t
hat these compounds may bind allosterically to a separate binding site
. Compounds with dihydropyridine structure with or without chemosensit
izing potency were also tested and some structure-activity relationshi
ps could be derived from the data. Our data show that inhibition of ph
otoaffinity labeling by [H-3]B9209-005 is a valuable and reliable syst
em for measuring the interaction with and potency of chemosensitizing
compounds at P-glycoprotein. Furthermore, data obtained in this test s
ystem are well suited to investigate structure-activity relationships
for chemosensitizers at P-glycoprotein. In addition cytostatics underl
ying P-glycoprotein-mediated multidrug resistance can be identified.